Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- N/A
Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.
- Status
- COMPLETED
- Phase
- PHASE1
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Afatinib Expanded Access Program
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test
- Status
- COMPLETED
- Phase
- PHASE4
Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306
- Status
- COMPLETED
- Phase
- PHASE1
Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection
- Status
- WITHDRAWN
- Phase
- PHASE3
Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1